# Nuclide record life-molecular-imaging (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/life-molecular-imaging/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "life-molecular-imaging" ;
  schema:name "Life Molecular Imaging"@en ;
  schema:alternateName "LMI"@en ;
  schema:description "A company that makes Neuraceq, an injectable radioactive tracer that lights up Alzheimer's plaques on a PET brain scan, and is now owned by Lantheus."@en ;
  schema:url <https://nuclide.cc/companies/life-molecular-imaging/>, <https://www.life-mi.com> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://neuraceq.com/>, <https://lantheusholdings.gcs-web.com/news-releases/news-release-details/lantheus-acquire-life-molecular-imaging-upfront-payment-350>, <https://trial.medpath.com/news/lantheus-completes-789-million-acquisition-of-life-molecular-imaging-gains-fda-approved-alzheimer-s-diagnostic-agent>, <https://www.prnewswire.com/news-releases/life-molecular-imaging-expands-neuraceq-florbetaben-f-18-injection-production-in-southern-california-302534927.html>, <https://www.biospace.com/press-releases/life-molecular-imaging-expands-neuraceq-florbetaben-f-18-injection-production-in-decatur-il> ;
  nuclide:status "active" ;
  nuclide:tag "PET tracer", "Alzheimer's imaging", "amyloid PET" ;
  schema:addressCountry "DE" ;
  nuclide:related <https://nuclide.cc/companies/lantheus/>, <https://nuclide.cc/companies/sofie-biosciences/>, <https://nuclide.cc/targets/grpr/>, <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/lu-177/> .